Aptus Capital Advisors LLC Buys 4,296 Shares of Colgate-Palmolive Company $CL

Key Points

• Aptus Capital Advisors LLC increased its stake in Colgate-Palmolive by 24.3%, acquiring an additional 4,296 shares, bringing its total holdings to 21,986 shares valued at approximately $2,060,000.
• Colgate-Palmolive announced a quarterly dividend of $0.52 per share, representing an annualized dividend of $2.08 and a yield of 2.4%, with a payout ratio of 58.43%.
• The company's stock currently holds a consensus price target of $98.92 with seven analysts rating it as a Buy, four as Hold, and one as Sell.

Aptus Capital Advisors LLC increased its position in shares of Colgate-Palmolive Company (NYSE:CL - Free Report) by 24.3% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 21,986 shares of the company's stock after acquiring an additional 4,296 shares during the period. Aptus Capital Advisors LLC's holdings in Colgate-Palmolive were worth $2,060,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds have also recently bought and sold shares of the company. Westend Capital Management LLC increased its position in Colgate-Palmolive by 111.1% during the first quarter. Westend Capital Management LLC now owns 266 shares of the company's stock worth $25,000 after buying an additional 140 shares during the last quarter. Cornerstone Planning Group LLC increased its position in Colgate-Palmolive by 1,913.3% during the first quarter. Cornerstone Planning Group LLC now owns 302 shares of the company's stock worth $28,000 after buying an additional 287 shares during the last quarter. Vermillion Wealth Management Inc. acquired a new position in Colgate-Palmolive during the fourth quarter worth $31,000. Accredited Wealth Management LLC acquired a new position in Colgate-Palmolive during the fourth quarter worth $34,000. Finally, Y.D. More Investments Ltd acquired a new position in Colgate-Palmolive during the first quarter worth $37,000. 80.41% of the stock is owned by institutional investors and hedge funds.

Colgate-Palmolive Stock Performance

Shares of NYSE:CL traded down $0.5010 during midday trading on Friday, hitting $85.7790. The company's stock had a trading volume of 4,087,413 shares, compared to its average volume of 5,056,872. The stock has a market capitalization of $69.33 billion, a price-to-earnings ratio of 24.10, a PEG ratio of 4.47 and a beta of 0.35. The stock's 50 day simple moving average is $87.60 and its 200 day simple moving average is $89.93. Colgate-Palmolive Company has a fifty-two week low of $82.40 and a fifty-two week high of $109.30. The company has a debt-to-equity ratio of 6.79, a quick ratio of 0.57 and a current ratio of 0.89.

Colgate-Palmolive (NYSE:CL - Get Free Report) last issued its quarterly earnings results on Friday, August 1st. The company reported $0.92 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.89 by $0.03. Colgate-Palmolive had a return on equity of 377.63% and a net margin of 14.55%.The company had revenue of $5.11 billion for the quarter, compared to the consensus estimate of $5.03 billion. During the same period last year, the business posted $0.91 earnings per share. The firm's revenue was up 1.0% compared to the same quarter last year. As a group, research analysts anticipate that Colgate-Palmolive Company will post 3.75 earnings per share for the current year.

Colgate-Palmolive Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Friday, August 15th. Investors of record on Friday, July 18th were paid a $0.52 dividend. This represents a $2.08 annualized dividend and a dividend yield of 2.4%. The ex-dividend date was Friday, July 18th. Colgate-Palmolive's dividend payout ratio (DPR) is presently 58.43%.

Wall Street Analysts Forecast Growth

Several equities analysts have commented on CL shares. Wall Street Zen downgraded shares of Colgate-Palmolive from a "buy" rating to a "hold" rating in a research report on Wednesday, May 7th. UBS Group lowered their target price on shares of Colgate-Palmolive from $109.00 to $106.00 and set a "buy" rating on the stock in a research report on Thursday, July 17th. Morgan Stanley lowered their target price on shares of Colgate-Palmolive from $104.00 to $96.00 and set an "overweight" rating on the stock in a research report on Monday, August 4th. Wells Fargo & Company lowered their price target on Colgate-Palmolive from $88.00 to $83.00 and set an "underweight" rating on the stock in a research report on Monday, August 4th. Finally, Barclays raised their price target on Colgate-Palmolive from $86.00 to $87.00 and gave the company an "equal weight" rating in a research report on Tuesday, July 15th. Seven equities research analysts have rated the stock with a Buy rating, four have issued a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat, Colgate-Palmolive currently has a consensus rating of "Moderate Buy" and a consensus price target of $98.92.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.